Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure

European Heart Journal

Volumn 33, Issue 8, 2012, Pages 1017-1026

  Rondelet, Benoit ^a   Dewachter, Cline ^a   Kerbaul, Franois ^a,b   Kang, Xin ^a   Fesler, Pierre ^a,c   Brimioulle, Serge ^a,d   Naeije, Robert ^a   Dewachter, Laurence ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b TIMONE HOSPITAL   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d ERASME HOSPITAL   (Belgium)

Author keywords

Apoptosis; Congenital heart disease; Left to right shunt; Pulmonary arterial hypertension; Right ventricle

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CASPASE 3; ENDOTHELIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; NATRIURETIC PEPTIDE PRECURSOR A; NATRIURETIC PEPTIDE PRECURSOR B; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL KV2.1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VOLTAGE GATED POTASSIUM CHANNEL;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIOLE; ARTERY COMPLIANCE; ARTERY MEDIA; ARTICLE; BRACHIOCEPHALIC TRUNK; CAPILLARY DENSITY; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; CYTOKINE RELEASE; DETERIORATION; DISEASE SEVERITY; ENZYME ACTIVATION; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; MEAN ARTERIAL PRESSURE; NONHUMAN; PIGLET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC PULMONARY SHUNT;

ANASTOMOSIS, SURGICAL; ANIMALS; APOPTOSIS; BRACHIOCEPHALIC TRUNK; CYTOKINES; HEMODYNAMICS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MYOCARDIUM; PULMONARY ARTERY; PULMONARY CIRCULATION; RNA, MESSENGER; SUS SCROFA; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84860174108     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr111     Document Type: Article

References (56)

1. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S55-S66.
2. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jais X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156-163.
3. Humbert M, Sitbon O, Yaici A, Montani D, O'Callaghan DS, Jais X, Parent F, Savale L, Natali D, Gunther S, Chaouat A, Chabot F, Cordier JF, Habib G, Gressin V, Jing ZC, Souza R, Simonneau G. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36: 549-555.
4. Champion HC, Michelakis ED, Hassoun P M. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009;120:992-1007.
5. Haddad F, Hunt SA, Rosenthal DN, Murphy D J. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008;117:1436-1448. (Pubitemid 351501496)
6. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel N F. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009;135:794-804.
7. Rendas A, Lennox S, Reid L. Aorta-pulmonary shunts in growing pigs. Functional and structural assessment of the changes in the pulmonary circulation. J Thorac Cardiovasc Surg 1979;77:109-118. (Pubitemid 9103560)
8. Hoffman JI, Rudolph AM, Heymann M A. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 1981;64:873-877. (Pubitemid 11028081)
9. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S, McEntee K, Wauthy P, Salmon I, Ketelslegers JM, Naeije R. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 2003;107:1329-1335. (Pubitemid 36314419)
10. Rondelet B, Kerbaul F, Van Beneden R, Hubloue I, Huez S, Fesler P, Remmelink M, Brimioulle S, Salmon I, Naeije R. Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2005;289:H2319-H2324. (Pubitemid 41698538)
11. Rondelet B, Kerbaul F, Van Beneden R, Motte S, Fesler P, Hubloue I, Remmelink M, Brimioulle S, Salmon I, Ketelslegers JM, Naeije R. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy. Circulation 2004;110:2220-2225. (Pubitemid 39372505)
12. Brimioulle S, Maggiorini M, Stephanazzi J, Vermeulen F, Lejeune P, Naeije R. Effects of low flow on pulmonary vascular flow-pressure curves and pulmonary vascular impedance. Cardiovasc Res 1999;42:183-192. (Pubitemid 29167083)
13. Brimioulle S, Wauthy P, Ewalenko P, Rondelet B, Vermeulen F, Kerbaul F, Naeije R. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003;284:H1625-H1630. (Pubitemid 36460775)
14. Dewachter C, Dewachter L, Rondelet B, Fesler P, Brimioulle S, Kerbaul F, Naeije R. Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med 2010;38:1405-1413.
15. Winer J, Jung CK, Shackel I, Williams P M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999;270:41-49. (Pubitemid 29230718)
16. Winer BJ, Brown DR, Michels K M. Statistical Principles in Experimental Design. eds. Chiappetta ME, Vaicunas J, Morris J M. 3rd edition. New York: Mc-Graw-Hill; 1991, 220-283.
17. Heath D, Edwards J E. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18: 533-547.
18. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel N F. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120:1951-1960.
19. Mani SK, Shiraishi H, Balasubramanian S, Yamane K, Chellaiah M, Cooper G, Banik N, Zile MR, Kuppuswamy D. In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium. Am J Physiol Heart Circ Physiol 2008;295:H314-H326.
20. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow M R. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997;100:2315-2324. (Pubitemid 27500155)
21. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch 1988;413:108-110. (Pubitemid 19005277)
22. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 1988; 255:H970-H973.
23. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991; 69:209-215.
24. Zhao XS, PanW, Bekeredjian R, Shohet R V. Endogenous endothelin-1 is required for cardiomyocyte survival in vivo. Circulation 2006;114:830-837. (Pubitemid 44268233)
25. Araki M, Hasegawa K, Iwai-Kanai E, Fujita M, Sawamura T, Kakita T, Wada H, Morimoto T, Sasayama S. Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes. J Am Coll Cardiol 2000;36:1411-1418.
26. Kobayashi T, Miyauchi T, Sakai S, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart. Am J Physiol 1999;276:H1197-H1206. (Pubitemid 29214133)
27. Pieske B, Beyermann B, Breu V, Loffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 1999;99:1802-1809. (Pubitemid 29181407)
28. Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Schnabel P, Shimada K, Takahashi M, Bohm M. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 1999;99: 2118-2123. (Pubitemid 29196795)
29. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006;47:887-893. (Pubitemid 44297560)
30. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-448. (Pubitemid 46474597)
31. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-2118. (Pubitemid 41134152)
32. Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C. Heart and lung VEGF mRNA expression in rats with monocrotalineor hypoxia-induced pulmonary hypertension. Am J Physiol 1998;275: H1948-H1956.
33. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005;115:2811-2821. (Pubitemid 41434408)
34. Klein M, Schermuly RT, Ellinghaus P, Milting H, Riedl B, Nikolova S, Pullamsetti SS, Weissmann N, Dony E, Savai R, Ghofrani HA, Grimminger F, Busch AE, Schafer S. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. Circulation 2008;118:2081-2090.
35. Ghofrani HA, Morrell NW, Hoeper MM, Olschewski H, Peacock AJ, Barst RJ, Shapiro S, Golpon H, Toshner M, Grimminger F, Pascoe S. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med 2010;182:1171-1177.
36. Cheng H, Force T. Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics. Circ Res 2010;106:21-34.
37. Campian ME, Hardziyenka M, de Bruin K, van Eck-Smit BL, de Bakker JM, Verberne HJ, Tan H L. Early inflammatory response during the development of right ventricular heart failure in a rat model. Eur J Heart Fail 2010;12:653-658.
38. Lambert V, Capderou A, Le Bret E, Rucker-Martin C, Deroubaix E, Gouadon E, Raymond N, Stos B, Serraf A, Renaud J F. Right ventricular failure secondary to chronic overload in congenital heart disease: an experimental model for therapeutic innovation. J Thorac Cardiovasc Surg 2010;139:1197-1204.
39. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann D L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-2059. (Pubitemid 32373007)
40. Malave HA, Taylor AA, Nattama J, Deswal A, Mann D L. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 2003; 123:716-724. (Pubitemid 36315483)
41. Mann D L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-998. (Pubitemid 35416635)
42. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1628-1631.
43. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell N W. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010; 122:920-927.
44. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger V L. Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation 2008; 118:625-631.
45. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson J T. Randomized, doubleblind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003;107:3133-3140. (Pubitemid 36793081)
46. Harris DM, Mills GD, Chen X, Kubo H, Berretta RM, Votaw VS, Santana LF, Houser S R. Alterations in early action potential repolarization causes localized failure of sarcoplasmic reticulum Ca2+ release. Circ Res 2005;96: 543-550. (Pubitemid 40463463)
47. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli G F. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996;78: 262-273. (Pubitemid 26040856)
48. Volk T, Nguyen TH, Schultz JH, Ehmke H. Relationship between transient outward K+ current and Ca2+ influx in rat cardiac myocytes of endo-and epicardial origin. J Physiol 1999;519:841-850. (Pubitemid 29462447)
49. Volk T, Nguyen TH, Schultz JH, Faulhaber J, Ehmke H. Regional alterations of repolarizing K+ currents among the left ventricular free wall of rats with ascending aortic stenosis. J Physiol 2001;530:443-455. (Pubitemid 32162332)
50. Nattel S, Maguy A, Le Bouter S, Yeh Y H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007;87:425-456. (Pubitemid 47084677)
51. Hyvelin JM, Gautier M, Lemaire MC, Bonnet P, Eder V. Adaptative modifications of right coronary myocytes voltage-gated K+ currents in rat with hypoxic pulmonary hypertension. Pflugers Arch 2009;457:721-730.
52. D'Souza SP, Davis M, Baxter G F. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 2004;101:113-129. (Pubitemid 38167564)
53. Kuroski-de Bold ML, de Bold A J. Stretch-secretion coupling in atrial cardiocytes. Dissociation between atrial natriuretic factor release and mechanical activity. Hypertension 1991;18:169-178.
54. Meirovich YF, Veinot JP, de Bold ML, Haddad H, Davies RA, Masters RG, Hendry PJ, de Bold A J. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant 2008;27:31-37.
55. Honsho S, Nishikawa S, Amano K, Zen K, Adachi Y, Kishita E, Matsui A, Katsume A, Yamaguchi S, Nishikawa K, Isoda K, RichesDW, Matoba S, Okigaki M, Matsubara H. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ Res 2009;105:1149-1158.
56. Kim SJ, Abdellatif M, Koul S, Crystal G J. Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway. Am J Physiol Heart Circ Physiol 2008;295:H130-H135.